FDA Inspection 1223082 — Laboratorios Zepol S.A.

Laboratorios Zepol S.A. — FEI 3004637474

The FDA completed an inspection of Laboratorios Zepol S.A. on November 17, 2023 in Curridabat. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 6 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 17, 2023
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Curridabat (Costa Rica)

Citations

IDCFRDescription
150521 CFR 211.122(d)Label storage access limited to authorized personnel
179621 CFR 211.80(d)Identification of Each Lot in Each Shipment
181021 CFR 211.160(a)Lab controls established, including changes
191821 CFR 211.166(a)(2)Stability sample storage conditions described
240121 CFR 211.194(a)(4)Complete Test Data
440221 CFR 211.192Written record of investigation incomplete